European Society of Minimally Invasive Neurological Therapy (ESMINT) recommendations for optimal interventional neurovascular management in the COVID-19 era

The Coronavirus Disease 2019 (COVID-19) pandemic began in December 2019 in Wuhan, China. The outbreak is due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Healthcare contamination and infection rates are thought to be very high (up to 29% in a recent Chinese publication1). These recommendations are not intended to overrule local official safety measures and guidelines but rather to give other insights and perspectives while facing this exceptional situation in the safest way possible for your patient, team, family and yourself.